Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
Faverin 50 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Round, biconvex, scored, white to off-white film coated tablets imprinted ‘291’ on both sides of the score. The tablet can be divided into equal halves. |
Each tablet contains 50 mg fluvoxamine maleate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fluvoxamine |
The mechanism of action of fluvoxamine is thought to be related to selective serotonin re-uptake inhibition in brain neurones. There is minimum interference with noradrenergic processes. Receptor binding studies have demonstrated that fluvoxamine has negligible binding capacity to alpha adrenergic, beta adrenergic, histaminergic, muscarine cholinergic, dopaminergic or serotonergic receptors. |
| List of Excipients |
|---|
|
Tablet cores: Mannitol Film-coat: Hypromellose |
PVC/PVdC/Aluminium press-through blister.
Pack sizes: 5, 10, 20, 30, 50, 60, 90, 100 and 250 tablets.
Not all pack sizes may be marketed.
Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
PL 46302/0034
Date of last renewal: 21/06/2009
| Drug | Countries | |
|---|---|---|
| FAVERIN | Albania, Australia, Cyprus, Hong Kong, Ireland, Malta, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
